Calgary, AB, April 7, 2025 – Alberta-based Solvet, a subsidiary of Alberta Veterinary Laboratories Ltd. (“AVL” of the “Company”), is proud to announce a strategic investment from Canadian-owned and operated Bonnefield Financial Inc. (“Bonnefield”), a leading agriculture-focused investment management firm, through its Bonnefield Agribusiness Fund.
Established in 2009 by Dr. Merle Olson and Dr. Barbara Olson, Solvet is a family-owned company that supplies animal health and pharmaceutical products to livestock producers, veterinarians and pet owners in Canada and around the world. As one of North America’s only animal health companies focusing on livestock welfare and pain management, Solvet’s work meets a critical need across several sectors.
“Since Solvet opened its doors, we’ve continued to be bold and ambitious in delivering ‘innovation by request’ to support our key partners and customers,” explained Lionel Gibbs, Solvet’s Chief Executive Officer. “This investment from Bonnefield allows us to keep advancing our work through a strong Canadian partnership. As the first-ever outside equity in Solvet, we see this as a clear endorsement of our work and the potential ahead.”
With this strategic investment, Solvet is better equipped to coordinate its product development, distribution channels, compounding clinic and innovation efforts, including advanced manufacturing, to meet the needs of industry. Working closely with Bonnefield, through its Agribusiness Fund, the Company’s work will be catalyzed.
“Solvet plays a critical role in advancing best practices for livestock care through its robust product portfolio and unique manufacturing capabilities,” stated Sam Doyle, Managing Partner at Bonnefield. “Through our investment, we are excited to support the growth of this Canadian agribusiness and ultimately benefit the livestock industries both within Canada and abroad.”
Bonnefield’s Agribusiness Fund is dedicated to supporting companies critical to strengthening Canada’s agricultural value chain. This latest investment in Solvet underscores Bonnefield’s commitment to advancing agricultural sustainability and food security.
“Solvet is a trusted leader in the animal health sector, developing and manufacturing products that meet the highest industry standards,” commented Dr. Barbara Olson, Solvet co-founder and VP of Quality & Regulatory Affairs. “This investment supports our expanded production capabilities, enhances market reach and accelerates research and development.”
For questions about the fund and its fundraising status contact investors@bonnefield.com.
FOR MORE INFORMATION:
Lionel Gibbs, Chief Executive Officer, Solvet
(403) 392-0158
lionel.gibbs@avetlabs.com
Andrea Gruza, President, Bonnefield
agruza@bonnefield.com
About Solvet: Founded by the Olson family in 2009, Solvet meets the veterinary pharmaceutical needs of producers and pet owners. With an innovative business model, they develop products by listening to customers and producing them at their headquarters in Calgary, Alberta, Canada. www.solvet.ca
About Bonnefield Financial: Bonnefield is a leading Canadian owned and operated farmland and agriculture investment manager, providing financing to progressive farmers and agricultural operators through land-lease and non-controlling capital solutions. Bonnefield is dedicated to preserving farmland for farming, and the firm partners with growth-oriented operators to help them grow, strengthen their balance sheet, and facilitate retirement and succession. www.bonnefield.com